212 related articles for article (PubMed ID: 24129131)
21. Withdrawal of medical therapies in axial spondyloarthritis: what would be the optimal trial design?
Kiltz U; Baraliakos X; Braun J; van der Heijde D
Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S47-50. PubMed ID: 24129137
[TBL] [Abstract][Full Text] [Related]
22. 'Treat to target' for rheumatoid arthritis in 2014--time tested triple therapy or logical biologics?
Mok MY; Danda D
Int J Rheum Dis; 2014 Jan; 17(1):1-3. PubMed ID: 24472259
[No Abstract] [Full Text] [Related]
23. The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.
Feuchtenberger M; Kleinert S; Scharbatke EC; Gnann H; Behrens F; Wittig BM; Greger G; Tony HP
Clin Exp Rheumatol; 2015; 33(3):321-9. PubMed ID: 25897681
[TBL] [Abstract][Full Text] [Related]
24. [Indications for and use of biologics in early rheumatoid arthritis based on the evidence].
Takeuchi T
Nihon Rinsho; 2009 May; 67(5):1043-9. PubMed ID: 19432131
[TBL] [Abstract][Full Text] [Related]
25. Special report: evidence on sequencing of conventional and biological disease-modifying anti-rheumatic drugs.
TEC Bull (Online); 2003 Nov; 20(3):24-9. PubMed ID: 15052992
[No Abstract] [Full Text] [Related]
26. Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
Plasencia C; Wolbink G; Krieckaert CL; Kneepkens EL; Turk S; Jurado T; Martínez-Feito A; Navarro-Compán V; Bonilla G; Villalba A; Peiteado D; Nuño L; Martín-Mola E; Nurmohamed MT; van der Kleij D; Rispens T; Pascual-Salcedo D; Balsa A
Clin Exp Rheumatol; 2016; 34(4):655-62. PubMed ID: 27214767
[TBL] [Abstract][Full Text] [Related]
27. Dose optimization of infliximab in patients with rheumatoid arthritis.
Alten R; van den Bosch F
Int J Rheum Dis; 2014 Jan; 17(1):5-18. PubMed ID: 24472261
[TBL] [Abstract][Full Text] [Related]
28. [Against parenteral gold therapy in rheumatoid arthritis].
Kellner H
Dtsch Med Wochenschr; 2011 Aug; 136(33):1677. PubMed ID: 21833892
[No Abstract] [Full Text] [Related]
29. Impact of rheumatoid arthritis in Turkey: a questionnaire study.
Direskeneli H; Akkoç N; Bes C; Cakir N; Cefle A; Cobankara V; Dalkilic E; Dinc A; Ertenli I; Gul A; Hamuryudan V; Inanc M; Kalyoncu U; Karaaslan Y; Kasifoglu T; Keser G; Keskin G; Kisacik B; Kiraz S; Masatlioglu S; Onat AM; Ozbek S; Ozturk MA; Pamuk ON; Pay S; Pirildar T; Sayarlioglu M; Senel S; Senturk T; Tasan D; Terzioglu E; Yazici A; Yucel E
Clin Exp Rheumatol; 2014; 32(4):477-83. PubMed ID: 24960289
[TBL] [Abstract][Full Text] [Related]
30. [Switching within the active ingredient group or changing the mechanism of action. Data situation by failure of the first line biologic].
Rubbert-Roth A
Z Rheumatol; 2015 Jun; 74(5):406-13. PubMed ID: 26031285
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
32. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
[TBL] [Abstract][Full Text] [Related]
33. Biologic discontinuation studies: a systematic review of methods.
Yoshida K; Sung YK; Kavanaugh A; Bae SC; Weinblatt ME; Kishimoto M; Matsui K; Tohma S; Solomon DH
Ann Rheum Dis; 2014 Mar; 73(3):595-9. PubMed ID: 23723316
[TBL] [Abstract][Full Text] [Related]
34. Making smart investment decisions in clinical research.
Bansback N; Keystone E; O'Dell J; Phibbs CS; Hannagan K; Brophy M; Anis A
Trials; 2015 Dec; 16():590. PubMed ID: 26712327
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy in early rheumatoid arthritis.
Gossec L; Dougados M
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S174-8. PubMed ID: 14969072
[TBL] [Abstract][Full Text] [Related]
36. Can biologic therapies be withdrawn or tapered in psoriatic arthritis?
Moverley AR; Coates LC; Helliwell PS
Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S51-3. PubMed ID: 24129138
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis.
Pincus T; Yazici Y; Sokka T; Aletaha D; Smolen JS
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S179-85. PubMed ID: 14969073
[TBL] [Abstract][Full Text] [Related]
38. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
Haschka J; Englbrecht M; Hueber AJ; Manger B; Kleyer A; Reiser M; Finzel S; Tony HP; Kleinert S; Feuchtenberger M; Fleck M; Manger K; Ochs W; Schmitt-Haendle M; Wendler J; Schuch F; Ronneberger M; Lorenz HM; Nuesslein H; Alten R; Demary W; Henes J; Schett G; Rech J
Ann Rheum Dis; 2016 Jan; 75(1):45-51. PubMed ID: 25660991
[TBL] [Abstract][Full Text] [Related]
39. Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry.
Favalli EG; Pregnolato F; Biggioggero M; Becciolini A; Penatti AE; Marchesoni A; Meroni PL
Arthritis Care Res (Hoboken); 2016 Apr; 68(4):432-9. PubMed ID: 26556048
[TBL] [Abstract][Full Text] [Related]
40. [Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission].
Mallick A; Fautrel B; Sagez F; Sordet C; Javier RM; Petit H; Chatelus E; Rahal N; Gottenberg JE; Sibilia J
Rev Med Interne; 2017 Apr; 38(4):256-263. PubMed ID: 28161110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
